2009

• Chung, L., Nelson, A., Ho, K., Baxter, R. Proteomic profiling of growth hormone responsive proteins in human peripheral blood leukocytes. The Journal of clinical endocrinology and metabolism. 2009; 94:3038-43. [Abstract]
• Chung, L., Baxter, R. Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 2009; 19:383-7. [Abstract]
• Gosby, A., Stanton, L., Maloney, C., Thompson, M., Briody, J., Baxter, R., Bryson, J., Denyer, G., Caterson, I. Postnatal nutrition alters body composition in adult offspring exposed to maternal protein restriction. The British journal of nutrition. 2009; 101:1878-84. [Abstract]
• Chan, S., Schedlich, L., Twigg, S., Baxter, R. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. American Journal of Physiology: Endocrinology and Metabolism. 2009; 296:E654-E663. [Abstract]

2008

• Nguyen, T., Nelson, A., Howe, C., Seibel, M., Baxter, R., Handelsman, D., Kazlauskas, R., Ho, K. Within-Subject Variability and Analytic Imprecision of Insulin-Like Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests. Clinical chemistry. 2008; 54:1268-76. [Abstract]
• Nelson, A., Meinhardt, U., Hansen, J., Walker, I., Stone, G., Howe, C., Leung, K., Seibel, M., Baxter, R., Handelsman, D., Kazlauskas, R., Ho, K. Pharmacodynamics of GH abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. The Journal of clinical endocrinology and metabolism. 2008; 93:2213-22. [Abstract]
• Marsh, D., Trahair, T., Martin, J., Chee, W., Walker, J., Kirk, E., Baxter, R., Marshall, G. Rapamycin treatment for a child with germline PTEN mutation. Nature clinical practice. Oncology. 2008; 5:357-61. [Abstract]
• Chuang, S., Patton, K., Schafernak, K., Papavero, V., Lin, F., Baxter, R., Teh, B., Yang, X. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. The Journal of Urology. 2008; 179:445-449. [Abstract]
• Baxter, R. Insulin-like Growth Factors and Tumor Hypoglycemia. In: Clinical Endocrine Oncology. United States: Wiley-Blackwell 2008. p. 576-581.

2007

• Schedlich, L., Muthukaruppan, A., O'han, M., Baxter, R. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the Vitamin D response in osteoblasts. Molecular endocrinology (Baltimore, Md.). 2007; 21:2378-90. [Abstract]
• Schedlich, L., Graham, L., O'han, M., Muthukaruppan, A., Yan, X., Firth, S., Baxter, R. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: Role in modulation of RAR-signaling. Archives of biochemistry and biophysics. 2007; 465:359-69. [Abstract]
• Scarlett, C., Samra, J., Xue, A., Baxter, R., Smith, R. Classification of pancreatic cystic lesions using seldi-tof mass spectrometry. ANZ journal of surgery. 2007; 77:648-653. [Abstract]
• Graham, M., Kilby, D., Firth, S., Robinson, P., Baxter, R. The in vivo phosphorylation and glycosylation of human insulin-like growth factor binding protein-5. Molecular & cellular proteomics : MCP. 2007; 6:1392-405. [Abstract]
• Martin, J., Baxter, R. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology. 2007; 148:2532-2541. [Abstract]
• Baxter, R., Smith, R., Scarlett, C., Xue, A., Butturini, G., Scarpa, A. Hp07 proteomic identification of serum markers of pancreatic adenocarcinoma using seldi-tof ms. ANZ journal of surgery. 2007; 77:A41-A41. [Abstract]
• Leong, S., Christopherson, R., Baxter, R. Profiling of Apoptotic Changes in Human Breast Cancer Cells Using SELDI-TOF Mass Spectrometry. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2007; 20:579-90. [Abstract]

2006

• Yan, X., Baxter, R., Perbal, B., Firth, S. The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3. Endocrinology. 2006; 147:5268-74. [Abstract]
• Nelson, A., Howe, C., Nguyen, T., Leung, K., Trout, G., Seibel, M., Baxter, R., Handelsman, D., Kazlauskas, R., Ho, K. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. The Journal of clinical endocrinology and metabolism. 2006; 91:4424-32. [Abstract]
• Scarlett, C., Saxby, A., Nielsen, A., Bell, C., Samra, J., Hugh, T., Baxter, R., Smith, R. Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology (Baltimore, Md.). 2006; 44:658-66. [Abstract]
• Scarlett, C., Smith, R., Saxby, A., Nielsen, A., Samra, J., Wilson, S., Baxter, R. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology. 2006; 130:1670-8. [Abstract]
• Santer, F., Bacher, N., Moser, B., Morandell, D., Ressler, S., Firth, S., Spoden, G., Sergi, C., Baxter, R., Jansen-Dürr, P., Zwerschke, W. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer research. 2006; 66:3024-33. [Abstract]
• Moscova, M., Marsh, D., Baxter, R. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Cancer research. 2006; 66:1376-83. [Abstract]
• Chung, L., Clifford, D., Buckley, M., Baxter, R. Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry. The Journal of clinical endocrinology and metabolism. 2006; 91:671-7. [Abstract]

2005

• Moscova, M., Marsh, D., Baxter, R. Identification of Cytokines regulated by phosphatidylinositol-3 kinase in ovarian cancer. Clinical Cancer Research. 2005; 11:8977S-8977S. [Abstract]
• Chan, S., Twigg, S., Firth, S., Baxter, R. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. The Journal of clinical endocrinology and metabolism. 2005; 90:6588-95. [Abstract]
• Sevette, A., Smith, R., Aslani, A., Kee, A., Hansen, R., Barratt, S., Baxter, R. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial. Clinical nutrition (Edinburgh, Lothian). 2005; 24:943-55. [Abstract]
• Nelson, A., Howe, C., Nguyen, T., Seibel, M., Baxter, R., Handelsman, D., Kazlauskas, R., Ho, K. Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletes. Clinical endocrinology. 2005; 63:305-9. [Abstract]
• Brand-Miller, J., Liu, V., Petocz, P., Baxter, R. The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. The American journal of clinical nutrition. 2005; 82:350-4. [Abstract]
• Butt, A., Dickson, K., Jambazov, S., Baxter, R. Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology. 2005; 146:3113-22. [Abstract]
• Takahashi, M., Papavero, V., Yuhas, J., Kort, E., Kanayama, H., Kagawa, S., Baxter, R., Yang, X., Gray, S., Teh, B. Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. International journal of oncology. 2005; 26:923-31. [Abstract]
• Healy, M., Dall, R., Gibney, J., Bassett, E., Ehrnborg, C., Pentecost, C., Rosen, T., Cittadini, A., Baxter, R., Sonksen, P. Toward the development of a test for growth hormone (GH) abuse: A study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. Journal of Clinical Endocrinology and Metabolism. 2005; 90:641-649. [Abstract]

2004

• Yan, X., Forbes, B., McNeil, K., Baxter, R., Firth, S. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. The Journal of biological chemistry. 2004; 279:53232-40. [Abstract]
• Scarlett, C., O'leary, M., Kee, A., Nielsen, A., Sevette, A., Baxter, R., Smith, R. A study of parenteral versus enteral nutrition following caecal ligation and puncture in the rat: Influence on survival and tissue protein turnover. Clinical nutrition (Edinburgh, Lothian). 2004; 23:1135-45. [Abstract]
• Mesotten, D., Wouters, P., Peeters, R., Hardman, K., Holly, J., Baxter, R., Van den Berghe, G. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. The Journal of clinical endocrinology and metabolism. 2004; 89:3105-13. [Abstract]
• Payet, L., Firth, S., Baxter, R. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. The Journal of clinical endocrinology and metabolism. 2004; 89:2382-9. [Abstract]
• Butt, A., Martin, J., Dickson, K., McDougall, F., Firth, S., Baxter, R. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. The Journal of clinical endocrinology and metabolism. 2004; 89:1950-6. [Abstract]
• Schedlich, L., O'Han, M., Leong, G., Baxter, R. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochemical and biophysical research communications. 2004; 314:83-8. [Abstract]

2003

• Mesotten, D., Van den Berghe, G., Liddle, C., Coulter, S., McDougall, F., Baxter, R., Delhanty, P. Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology. 2003; 144:4008-17. [Abstract]
• Butt, A., Dickson, K., McDougall, F., Baxter, R. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. The Journal of biological chemistry. 2003; 278:29676-85. [Abstract]
• Payet, L., Wang, X., Baxter, R., Firth, S. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. Endocrinology. 2003; 144:2797-806. [Abstract]
• Frystyk, J., Nyholm, B., Skjaerbaek, C., Baxter, R., Schmitz, O., Ørskov, H. The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects. Clinical endocrinology. 2003; 58:777-84. [Abstract]
• Schedlich, L., Nilsen, T., John, A., Jans, D., Baxter, R. Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology. 2003; 144:1984-93. [Abstract]
• Srinivasan, S., Waters, M., Rowland, J., Baxter, R., Verge, C. Hyperinsulinism and overgrowth without obesity. Archives of disease in childhood. 2003; 88:332-4. [Abstract]
• Gunton, J., Delhanty, P., Takahashi, S., Baxter, R. Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. The Journal of clinical endocrinology and metabolism. 2003; 88:1323-32. [Abstract]
• Martin, J., Weenink, S., Baxter, R. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. The Journal of biological chemistry. 2003; 278:2969-76. [Abstract]
• Le Roith, D., Zumkeller, W., Baxter, R. Insulin-like Growth Factor Receptor Signalling. Netherlands: Kluwer, 2003.
• Ehrnborg, C., Lange, K., Dall, R., Christiansen, J., Lundberg, P., Baxter, R., Boroujerdi, M., Bengtsson, B., Healey, M., Pentecost, C., Longobardi, S., Napoli, R., Rosén, T., , G. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. The Journal of clinical endocrinology and metabolism. 2003; 88:394-401. [Abstract]
• Fanayan, S., Baxter, R. Functional relationships between transforming growth factor-beta and the insulin-like growth factor binding proteins. In: Insulin-Like Growth Factors. New York: Kluwer Academic/Plenum Publishers 2003. p. 281-293.